Detailed examination of Nanopharmaceuticals market By top key vendors like Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy


This report studies the Nanopharmaceuticals market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.

Get Sample Copy of this report:

Top Key Operating Vendors:
Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.

USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.

The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.

By the product type, the market is primarily split into
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion

By the end users/application, this report covers the following segments
Cancer and Tumor
Autoimmune Disorders

The study objectives of this report are:
To study and analyze the global Nanopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Nanopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nanopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Nanopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Early buyers will receive up to 40% Discount on this report:

Table Of Content:

Chapter 1 Industry Overview of Nanopharmaceuticals

Chapter 2 Manufacturing Cost Structure Analysis of Nanopharmaceuticals

Chapter 3 Technical Data and Manufacturing Plants Analysis of Nanopharmaceuticals

Chapter 4 Global Nanopharmaceuticals Overall Market Overview

Chapter 5 Nanopharmaceuticals Regional Market Analysis

Chapter 6 Major Manufacturers Analysis of Nanopharmaceuticals

Chapter 7 Development Trend of Analysis of Nanopharmaceuticals Market

Chapter 8 Nanopharmaceuticals Marketing Type Analysis

Chapter 9 Conclusion of the Global Nanopharmaceuticals Market Professional Survey Report 2019

, , , , , , , , , , , , , , , , , , , , , , , , , ,